Global Dosimetry Solutions, Inc., President to Retire Following 34-Year Tenure COSTA MESA, Calif., May 13 /PRNewswire/ -- Global Dosimetry Solutions, Inc., (GDS) a leading provider of dosimetry services (analytical determination of exposure to ionizing radiation), has announced that Sandra (Sandi) Nemecek, the company's president and a founding employee plans to retire at the end of the year. Nemecek began her career with GDS in 1970 and rose through the ranks. In 1978, Nemecek accepted the opportunity to manage a small product line called "Dosimetry" located in Cleveland, Ohio. In 1985, she relocated the business to the current location in Costa Mesa, Calif. Throughout her 34-year tenure, Nemecek has enjoyed enormous success in building the company from a small product line into a dominant, global dosimetry service. "Sandi has been a key contributor to the success of GDS -- her experience and guidance in the business along with her excellent reputation in the marketplace have been instrumental in making the company what it is today," said Robert Klein, Managing Director of majority owner American Capital. "Sandi will continue to serve in a leadership role for the remainder of 2004, and will ensure a smooth transition with her successor." About Global Dosimetry Solutions Global Dosimetry Solutions, based in Costa Mesa, California, is one of the world's largest providers of radiation dosimetry services. GDS offers a full range of services for measuring ionizing radiation primarily through film, thermoluminescent and track etch technologies. Since early 1970, the company has continually provided state-of-the-art personal radiation monitoring services to hospitals, medical and dental offices, university and national laboratories, nuclear power plants and other industries. GDS provides services to more than 500,000 people globally. For more information, please visit: http://www.dosimetry.com/. About American Capital Strategies, Ltd. American Capital (NASDAQ:ACAS) is a publicly traded buyout and mezzanine fund with capital resources in excess of $2.7 billion. American Capital is an investor in and sponsor of management and employee buyouts; invests in private equity sponsored buyouts, and provides capital directly to private and small public companies. American Capital provides senior debt, mezzanine debt and equity to fund growth, acquisitions and recapitalizations. Companies interested in learning more about American Capital's flexible financing should contact Mark Opel, Principal, at (800) 248-9340, or visit their website. DATASOURCE: Global Dosimetry Solutions, Inc. CONTACT: Monica Golden of True Parallel, +1-714-273-2776, , for Global Dosimetry Solutions, Inc. Web site: http://www.dosimetry.com/

Copyright

American Capital Strategies (NASDAQ:ACAS)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024 American Capital Strategies 차트를 더 보려면 여기를 클릭.
American Capital Strategies (NASDAQ:ACAS)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024 American Capital Strategies 차트를 더 보려면 여기를 클릭.